TGF-β in developmental and fibrogenic EMTs

Semin Cancer Biol. 2022 Nov;86(Pt 2):136-145. doi: 10.1016/j.semcancer.2022.09.004. Epub 2022 Sep 29.

Abstract

TGF-β plays a prominent role as an inducer of epithelial-mesenchymal transitions (EMTs) during development and wound healing and in disease conditions such as fibrosis and cancer. During these processes EMT occurs together with changes in cell proliferation, differentiation, communication, and extracellular matrix remodeling that are orchestrated by multiple signaling inputs besides TGF-β. Chief among these inputs is RAS-MAPK signaling, which is frequently required for EMT induction by TGF-β. Recent work elucidated the molecular basis for the cooperation between the TGF-β-SMAD and RAS-MAPK pathways in the induction of EMT in embryonic, adult and carcinoma epithelial cells. These studies also provided direct mechanistic links between EMT and progenitor cell differentiation during gastrulation or intra-tumoral fibrosis during cancer metastasis. These insights illuminate the nature of TGF-β driven EMTs as part of broader processes during development, fibrogenesis and metastasis.

Keywords: Cancer; Development; EMT; Fibrosis; TGF-β.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Epithelial-Mesenchymal Transition* / genetics
  • Fibrosis
  • Humans
  • Neoplasm Metastasis
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Transforming Growth Factor beta* / metabolism

Substances

  • Transforming Growth Factor beta